170 related articles for article (PubMed ID: 23337048)
1. Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia.
Enger C; Jones ME; Kryzhanovskaya L; Doherty M; McAfee AT
Int J Adolesc Med Health; 2013; 25(1):3-11. PubMed ID: 23337048
[TBL] [Abstract][Full Text] [Related]
2. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
3. A predisposition for allergies predicts subsequent hypertension, dyslipidemia, and diabetes mellitus among patients with schizophrenia or bipolar disorder: a nationwide longitudinal study.
Chen MH; Li CT; Lin WC; Wei HT; Chang WH; Chen TJ; Pan TL; Su TP; Bai YM
Schizophr Res; 2014 Oct; 159(1):171-5. PubMed ID: 25115406
[TBL] [Abstract][Full Text] [Related]
4. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
[TBL] [Abstract][Full Text] [Related]
5. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
7. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
8. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS; Tripathi A
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
[TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
10. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
[TBL] [Abstract][Full Text] [Related]
11. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
McIntyre RS
J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
[TBL] [Abstract][Full Text] [Related]
12. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada.
Callaghan RC; Khizar A
J Affect Disord; 2010 Apr; 122(1-2):118-23. PubMed ID: 19647877
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression.
Diaz FJ; James D; Botts S; Maw L; Susce MT; de Leon J
Bipolar Disord; 2009 Mar; 11(2):154-65. PubMed ID: 19267698
[TBL] [Abstract][Full Text] [Related]
15. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
Laursen TM; Agerbo E; Pedersen CB
J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.
Liao CH; Chang CS; Wei WC; Chang SN; Liao CC; Lane HY; Sung FC
Schizophr Res; 2011 Mar; 126(1-3):110-6. PubMed ID: 21216567
[TBL] [Abstract][Full Text] [Related]
17. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study.
Bai YM; Su TP; Chen MH; Chen TJ; Chang WH
J Affect Disord; 2013 Aug; 150(1):57-62. PubMed ID: 23510547
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study.
Jennex A; Gardner DM
Can J Psychiatry; 2008 Jan; 53(1):34-42. PubMed ID: 18286870
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of hyperlipidemia in patients with bipolar disorder: a population-based study.
Hsu JH; Chien IC; Lin CH
Gen Hosp Psychiatry; 2015; 37(4):294-8. PubMed ID: 25892153
[TBL] [Abstract][Full Text] [Related]
20. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
